280 likes | 1.16k Views
Genetics and Pathogenesis of Polycystic Kidney Disease. Maria Abreu. What is polycystic kidney disease?. Autosomal dominant disease One of the most common hereditary disorders.
E N D
Genetics and Pathogenesis of Polycystic Kidney Disease Maria Abreu
What is polycystic kidney disease? • Autosomal dominant disease • One of the most common hereditary disorders. • Characterized by cyst formation in ductal organs: kidneys and the liver, and by GI, cardiovascular, and musculoskeletal abnormalities.
Identification and Characterization of Polycystin-2, the PKD2 Gene product Cai, Y., Y. Maeda, A. Cedzich, V.E. Torres, G. Wu, T. Hayashi, T. Mochizuki, J.H. Park, R. Witzgall, and S. Somlo. Identification and characterization of polycystin-2, the PKD2 gene product. 1999. Journal of Biological Chemistry 274 (40): 28557-28565.
Autosomal Dominant Polycystic Kidney Disease (ADPKD) • ADPKD is caused by mutations in two genes, PKD1 and PKD2. • Mapped to chromosomes 16p13.3 and 4q13-p23 respectively
PKD2 gene • Expressed in many tissues and organs • Mutated in 15% of affected families • Encodes for polycystin-2 • Highly conserved in multicellular organisms • Loss of functional polycystin-2 in renal tubule and biliary epithelial cells causes cells to proliferate, loss their normal structure within tissue architecture, and go on to form cysts.
What is the focus of the paper? • Want to identify and characterize polycystin-2 as an integral membrane glycoprotein whose predominant subcellular location is in the ER.
Glycoproteins are complexes in which carbohydrates are attached covalently to asparagine (N-glycans) or serine/threonine (O-glycans) residues of peptides. http://www.glycoforum.gr.jp/science/word/glycoprotein/GPA00E.html
Use of polyclonal antisera against intracellular domains of polycystin-2 • Protein C2 (a.a. 687-962) contains most of the cytoplasmic COOH-terminal portion of polycystin-2 • B9(a.a. 103-203) contains part of the NH2- terminal portion of polycystin-2
http://www.biocenter.helsinki.fi/bi/peranen/Kotisivunlinkit/Vectors/pGEX-2TL.htmhttp://www.biocenter.helsinki.fi/bi/peranen/Kotisivunlinkit/Vectors/pGEX-2TL.htm
Expression Plasmids • Full length PKD2 cDNA (TM4-FL) was constructed. • Introduced naturally occuring mutations (R742X and R872X) into TM4-FL by site-directed mutagenesis. • Truncation constructs: introducing stop codons. (E877X and G821X)
Primers designed R742X5’-GTTAAACTTTGACGAACTTTGACAAGATCTCAAAGGGAAG-3’ E787X 5’-GACTTGGAGAAAGAGAGGTAAGACCTGGATTTGGATC-3’
Cell culture and Transfections • HEK293 cell lines expressing TM4-FL were selected with Zeocin (antibiotic). • Individual colonies selected and tested by immunoblotting and immocytochemistry for expression of polycystin-2 using YCC2 and YCB9 antisera. • Resistant colonies were cultured individually and tested for the expressin of the full-length and truncated PKD2 proteins.
Western Blots and Immunoprecipitation • Proteins subjected to electrophoresis. • Fractioned proteins were electrotransfered to membrane and detected with YCC2 and YCB9 polyclonal antisera.
Glycoproteins are complexes in which carbohydrates are attached covalently to asparagine (N-glycans) or serine/threonine (O-glycans) residues of peptides. http://www.glycoforum.gr.jp/science/word/glycoprotein/GPA00E.html
Conclusion • PKD2 is an integral membrane protein that is widely expressed and highly conserved in mammalian cells and tissues tested. • NH2 terminus appears to be intracellular • Polycystin-2 is an Endo-H sensitive glycoprotein • Polycystin-2 is predominantly present in the endoplasmic reticulum.
Products of PKD1 & PKD2 are transmembrane proteins & a membrane-bound calcium channel
Thank you! Questions?